[HTML][HTML] Expression of PD-L1 in Early-Stage Invasive Breast Carcinoma and Its Relation to Tumor-Infiltrating Lymphocytes

NH Amin, AA Abou-Bakr, S Eissa… - Asian Pacific Journal …, 2022 - ncbi.nlm.nih.gov
… A) Hematoxylin and Eosin image of a case high grade invasive duct carcinoma (x400). B)
Immunostaining image of PD-L1 positive membranous expression in tumor cells (x400). C) …

The clinicopathological and prognostic value of PD-L1 expression in cholangiocarcinoma: a meta-analysis

G Xu, L Sun, Y Li, F Xie, X Zhou, H Yang, S Du… - Frontiers in …, 2019 - frontiersin.org
duct cancer” or “bile duct cancer” or “bile duct carcinoma” or “… the DFS and PD-L1 in TCs and
the association of PD-L1 in ICs … evidence about significant prognostic role of PD-L1 in CCA. …

[HTML][HTML] Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers

K Mody, J Starr, M Saul, K Poorman… - Journal of …, 2019 - ncbi.nlm.nih.gov
… alterations with PD-1/PD-L1 expression … PD-1 and PD-L1 in a large cohort of samples
of BTCs collected from multiple locations, and (II) to assess for associations between PD-1/PD-L1

[HTML][HTML] PD-L1 expression in pancreaticobiliary adenosquamous carcinoma: a single-institution case series

JD Ward, M Fowler, A Robledo-Gomez… - Journal of …, 2024 - ncbi.nlm.nih.gov
… No cases of intrahepatic or extrahepatic bile-duct ASC were found in our record and thus,
biliary tract carcinomas in this study are virtually limited to gallbladder lesions. Resection …

Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection

AC Glencer, JM Wong, NM Hylton, G Krings… - NPJ breast …, 2021 - nature.com
Ductal carcinoma in situ (DCIS) is a risk factor for the subsequent development of invasive
breast cancer. High-risk features include age <45 years, size >5 cm, high-grade, palpable …

… TILs) and PD-L1 expression correlate with lymph node metastasis, high-grade transformation and shorter metastasis-free survival in patients with acinic cell carcinoma …

S Hiss, M Eckstein, P Segschneider, K Mantsopoulos… - Cancers, 2021 - mdpi.com
… compared to other salivary gland carcinomas PD-L1 [27]. The … PD-L1 expression with PD-L1
28-8 clone. For the first time, our present study demonstrates an association between PD-L1

PD-L1 expression as a predictive biomarker in patients with recurrent or metastatic salivary gland carcinoma treated with pembrolizumab

T Matsuki, D Kawakita, H Takahashi, T Okada… - Scientific Reports, 2024 - nature.com
… Representative images of the tumor before and during pembrolizumab monotherapy in a
patient with pancreatic metastasis of salivary duct carcinoma. (a) Pre-treatment of the patient …

[HTML][HTML] Expression of PD-L1 in Locally Advanced Breast Cancer and Its Impact on Neoadjuvant Chemotherapy Response

MA Hussein, HAR Ismail, M Saqr… - Asian Pacific Journal of …, 2022 - ncbi.nlm.nih.gov
… high grade invasive duct carcinoma (x400); B, Immunostaining image of PD-L1 positive … a
high frequency of PD-L1 expression in advanced breast carcinomas, which is consistent with …

Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma

L Bugia, F Jungbauer, L Zaubitzer… - Journal of …, 2024 - journals.lww.com
… the patient was diagnosed with salivary duct carcinoma of the parotid gland with … PDL1
status of the most recent tumor material, that is, lung metastasis tissue was assessed. The PD-L1

PDL1 and PD‑1 expression correlate with prognosis in extrahepatic cholangiocarcinoma

K Ma, X Wei, D Dong, Y Wu, Q Geng… - Oncology …, 2017 - spandidos-publications.com
… rate of PD-L1 expression in bile duct cells of ECC tissues was 42.86% (30/70), while the
positive rate in para-carcinoma … were increased compared with those in para-carcinoma tissues. …